ACHN - Achillion up 3% premarket on positive ACH-5228 data July, 22 2019 09:01 AM Achison Inc Cl A Achillion Pharmaceuticals (NASDAQ:ACHN) announces results from their Phase 1 multiple ascending dose study with ACH-5228 outside U.S.More news on: Achillion Pharmaceuticals, Inc., Healthcare stocks news, Stocks on the move, Read more ...